Related references
Note: Only part of the references are listed.Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases
Alessandro Antonelli et al.
AUTOIMMUNITY REVIEWS (2014)
CD40 immunotherapy for pancreatic cancer
Robert H. Vonderheide et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Myeloid-derived suppressor cells in cancer: recent progress and prospects
Yazan S. Khaled et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Vaccine Injection Site Matters: Qualitative and Quantitative Defects in CD8 T Cells Primed as a Function of Proximity to the Tumor in a Murine Glioma Model
John R. Ohlfest et al.
JOURNAL OF IMMUNOLOGY (2013)
Profound Impairment of Adaptive Immune Responses by Alkylating Chemotherapy
Adam J. Litterman et al.
JOURNAL OF IMMUNOLOGY (2013)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
P. Allavena et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Differentiation and gene expression profile of tumor-associated macrophages
Astrid Schmieder et al.
SEMINARS IN CANCER BIOLOGY (2012)
COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
Mitsugu Fujita et al.
CANCER RESEARCH (2011)
Aberrant PGE2 metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells
Evgeniy Eruslanov et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
Joris D. Veltman et al.
BMC CANCER (2010)
CD40 is a regulator for vascular endothelial growth factor in the tumor microenvironment of glioma
Fang Xie et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Arginase: an emerging key player in the mammalian immune system
Markus Munder
BRITISH JOURNAL OF PHARMACOLOGY (2009)
TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma
M. Enderlin et al.
CANCER GENE THERAPY (2009)
De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA
Stephen M. Wiesner et al.
CANCER RESEARCH (2009)
Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells-Significant Roles of CXCL10
Mitsugu Fujita et al.
CANCER RESEARCH (2009)
Altered Expression of 15-Hydroxyprostaglandin Dehydrogenase in Tumor-Infiltrated CD11b Myeloid Cells: A Mechanism for Immune Evasion in Cancer
Evgeniy Eruslanov et al.
JOURNAL OF IMMUNOLOGY (2009)
Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma
Xiao-bing Jiang et al.
VACCINE (2009)
Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma
Mitsugu Fujita et al.
JOURNAL OF IMMUNOLOGY (2008)
Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics
Naoki Umemura et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells
Pratima Sinha et al.
CANCER RESEARCH (2007)
Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-α
Hillary D. Lum et al.
IMMUNOLOGY (2006)
In vivo CD40 ligation can induce T cell-independent antitumor effects that involve macrophages
Hillary D. Lum et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: Critical roles of IFN-inducible protein-10
F Nishimura et al.
CANCER RESEARCH (2006)
Identification of a glioma antigen, GARC-1, using cytotoxic T lymphocytes induced by HSV cancer vaccine
Y Iizuka et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
PC Rodriguez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
CD40 ligation activates murine macrophages via an IFN-γ-dependent mechanism resulting in tumor cell destruction in vitro
IN Buhtoiarov et al.
JOURNAL OF IMMUNOLOGY (2005)
Death receptor-mediated apoptosis in human malignant glioma cells: Modulation by the CD40/CD40L system
J Wischhusen et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs
T Calzascia et al.
IMMUNITY (2005)
CD40 stimulation leads to effective therapy of CD40-tumors through induction of strong systemic cytotoxic T lymphocyte immunity
GJD van Mierlo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
CD40 ligation for immunotherapy of solid tumours
SM Todryk et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Anti-CD40 antibody induces antitumor and antimetastatic effects: The role of NK cells
JG Turner et al.
JOURNAL OF IMMUNOLOGY (2001)
Role for CD40-CD40 ligand interactions in the immune response to solid tumours
AB Alexandroff et al.
MOLECULAR IMMUNOLOGY (2000)
Share Paper
